| Literature DB >> 25435912 |
Eleonora Di Gregorio1, Elisa Savin2, Elisa Biamino3, Elga Fabia Belligni3, Valeria Giorgia Naretto2, Gaetana D'Alessandro2, Giorgia Gai2, Franco Fiocchi2, Alessandro Calcia4, Cecilia Mancini4, Elisa Giorgio4, Simona Cavalieri1, Flavia Talarico2, Patrizia Pappi2, Marina Gandione5, Monica Grosso6, Valentina Asnaghi6, Gabriella Restagno6, Giorgia Mandrile7, Giovanni Botta8, Margherita Cirillo Silengo3, Enrico Grosso2, Giovanni Battista Ferrero3, Alfredo Brusco1.
Abstract
BACKGROUND: Conventional karyotyping (550 bands resolution) is able to identify chromosomal aberrations >5-10 Mb, which represent a known cause of intellectual disability/developmental delay (ID/DD) and/or multiple congenital anomalies (MCA). Array-Comparative Genomic Hybridization (array-CGH) has increased the diagnostic yield of 15-20%.Entities:
Keywords: Array-CGH; CNV; GTG-banding; Genomic rearrangement; Intellectual disability; Unbalanced derivative chromosomes
Year: 2014 PMID: 25435912 PMCID: PMC4247713 DOI: 10.1186/s13039-014-0082-7
Source DB: PubMed Journal: Mol Cytogenet ISSN: 1755-8166 Impact factor: 2.009
Figure 1Array-CGH and karyotyping in cases with inherited and chromosomal rearrangements. Panel A. Array-CGH analysis resulting in telomeric rearrangements on two different chromosomes (left). On the X-axis, the log ratio is reported (log2 intensity of [Cy5 fluorochrome/Cy3 fluorochrome)]. Expected values are from −0.7 to −1 for a deletion (green dots), 0 for normal (black dots), and +0.5 to +1 for a duplication (red dots). On the right side, GTG-banding of the chromosomes involved in the structural rearrangements. In cases marked by an asterisk, the chromosomes on the right are from the parent carrying the cryptic translocation, because patient karyotype image was not available. Breakpoints are indicated by red bars on chromosomal ideograms. In panel B, array-CGH analysis displays telomeric rearrangements in probands with de novo rearrangements.
Figure 2FISH analysis of the parents carrying balanced translocation. FISH probes hybridize on the normal homologues as well as on derivative chromosomes. Probes used in these analysis were the following: 3q SpectrumOrange (05 J04-003, Vysis TelVysion probe, Abbot, Illinois, USA), 4q SpectrumOrange (05 J04-004, Vysis TelVysion probe), 10p SpectrumGreen (05 J03-010, Vysis TelVysion probe), 10q SpectrumOrange (05 J04-010, Vysis TelVysion probe), 12p SpectrumGreen (05 J03-012, Vysis TelVysion probes), 12q SpectrumOrange (05 J04-012, Vysis TelVysion probe),15q SpectrumOrange (05 J04-015, Vysis TelVysion probe), painting 14 (LPP14R, CYTOCELL, Cambridge, UK), Prader-Willi/Angelman Region probe -LSI SNRP Spectrum orange/CEP15 (D15Z1) SpectrumAqua/LSI PML SpectrumGreen (05 J26-027, Vysis, Abbot).
Summary of the seven patients with large rearrangement missed by karyotype
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
|
| DGT283320 | M | arr 10q26.13q26.3(124,500,982-135,404,471)x1, 12q24.31q24.33(125,178,836-133,819,092)x3 | 10.9: 8.6 | maternal translocation | Amniocytes |
|
| DGT283326 | F | arr 11q24.3q25(128,728,456-134,868,407)x1, 20q13.3(58,442,781-62,893,189)x3, | 6: 4.4 |
| Periph. Blood |
|
| DGT283327 | M | arr 4q34.1q35.2(172,930,618-190,896,674)x3, 9p24.3p23(271,257-12,907,826)x1, 14q21.1(43,881,311-44,623,069)x3 | 18: 12.6: 0.74 | maternal translocation | Periph. Blood |
|
| DGT283328 | M | arr 10p15.3p13(148,206-12,211,671)x1, 12q24.31q24.33(121,572,578-133,767,986)x3 | 12: 12.2 | paternal translocation | Periph. Blood |
|
| DGT283329 | M | arr 3q27.1q29(184,428,168-197,840,339)x3, 15q26.1q26.3( 90,857,664-102,383,473)x1 | 13: 11.5 | paternal translocation | Amniocytes |
|
| DGT283330 | M | arr 2p12p11.2(82,510,808-84,804,525)x1, 14q11.2q12(20,472,548-31,139,579)x3, 15q11.1q14(20,102,541-35,758,169)x1 | 2.2: 10.7: 15.6 | maternal translocation | Periph. Blood |
|
| DGT290945 | F | arr 7p22.3p22.2 (92.532-4.176.031)x3, 7p22.3p22.2 (7.044.310-15.709.683)x3, 11q24.1q25(122.467.330-134.868.407)x1 | 4: 8.6: 12.4 |
| Chorionic villi |
Genes involved in the rearrangements and their associated phenotypes
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
| del 10q26.13q26.3 | 76 | 3 (AR) | - | ||
| 4 yrs | dup 12q24.31q24.33 | 54 | 1 (ADdn) | - | ||
| 3 (AR) | ||||||
|
| 10 yrs | del 11q24.3q25 | 29 | 1 (ADdn) | - | |
| 4 (AR) | ||||||
| dup 20q13.3 | 90 | 7 (ADh) | - | |||
|
| 6 yrs | del 9p24.3p23 | 29 | 1 (ADdn) |
| Patient too young to verify symptoms |
| 4 (AR) |
| Intellectual disability, delayed speech, psychomotor development stooped posture and seizures | ||||
| 1 (AD) |
| Intellectual disability | ||||
| dup 4q34.1q35.2 | 53 | 9 (AR) |
| Patient too young to verify symptoms | ||
| dup 14q21.1 | Gene desert | - | ||||
|
| 15 yrs | del 10p15.3p13 | 73 | 3 (ADh) |
| Congenital hypoparathyroidism, deafness and renal disease |
| 1 (AR) |
| Cryptorchidism, hypospadia | ||||
|
| Patient too young to verify symptoms | |||||
| dup 12q24.31q24.33 | 108 | 1 (ADh) |
| May duplication affect hearing ability? | ||
| 1 (ADdn) | ||||||
| 9 (AR) | ||||||
|
| TOP | del 15q26.1q26.3 | 30 | 4 (ADh) |
| - |
|
| Ventricular septal defect | |||||
| 7 (AR) |
| IntraUterine Growth Retardation Heart malformation? | ||||
| dup 3q27.1q29 | 114 | 4 (ADh) |
| May duplication cause limb anomalies? | ||
| 1 (AD?) |
| |||||
| 9 (AR) | ||||||
|
| 1 yr | del 2p12p11.2 | 1 | 1 (AR) | ||
| del 15q11.1q14 | 60 | 5 (AR) |
| Patient too young to verify symptoms | ||
|
| Patient too young to verify symptoms | |||||
|
| Maternally inherited deletion | |||||
| 7 (ADh) |
| Angelman features (maternally inherited deletion) | ||||
|
| Myoclonic seizures | |||||
| dup 14q11.2q12 | 60 | 4 ADh |
| Patient too young to verify symptoms | ||
| 1 (ADgain) |
| Duplication may be associated with psychomotor developmental delay | ||||
| 2 (AD?) |
| Pervious foramen ovale | ||||
| 6 (AR) |
| Duplication may be associated with neurocognitive impairment | ||||
| del 11q24.1q25 | 58 | 3 (ADh) |
| - | ||
|
| TOP | 1 (AD?) |
| Brain malformation | ||
| 10 (AR) |
| - | ||||
| dup 7p22.3p22.2 | 42 | 4 (AR) |
|
Notes: aAR: autosomal recessive; ADdn: autosomal dominant, dominant negative effect; ADh: autosomal dominant, haploinsufficiency; AD?: autosomal dominant, unknown effect; ADgain: autosomal dominant with gain of function. TOP: Termination of Pregnancy.
Figure 3Dysmorphological features of cases 1, 3 and 4. A. Subject 1 at 18 months, shows mild facial dysmorphisms (triangular face, epicanthus, thin upper lip). B. Subject 3 (proband) at 6 yrs., dolico-trigonocephaly, thick eyebrows, mild synophris, mid-face hypoplasia. C. Younger brother of subject 3 at 2 yrs. showing similar dysmorphisms. D. Subject 4 at 14 yrs., showing bristly hair, left palpebral ptosis, broad nasal root, small ears.